Marchesi N, Fahmideh F, Boschi F, Pascale A, Barbieri A. Ocular neurodegenerative diseases: interconnection between retina and cortical areas. Cells. 2021;10(9):2394.
PubMed PubMed Central Article Google Scholar
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–90.
Sharif NA. Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision. Neural Regen Res. 2018;13(7):1145–50.
PubMed PubMed Central Article Google Scholar
Casson RJ, Chidlow G, Wood JP, Crowston JG, Goldberg I. Definition of glaucoma: clinical and experimental concepts. Clin Exp Ophthalmol. 2012;40(4):341–9.
Heijl A, Bengtsson B, Oskarsdottir SE. Prevalence and severity of undetected manifest glaucoma: results from the early manifest glaucoma trial screening. Ophthalmology. 2013;120(8):1541–5.
Jammal AA, Thompson AC, Mariottoni EB, Urata CN, Estrela T, Berchuck SI, et al. Rates of glaucomatous structural and functional change from a large clinical population: the Duke Glaucoma Registry Study. Am J Ophthalmol. 2021;222:238–47.
Tamm ER, Ethier CR, Dowling JE, Downs C, Ellisman MH, Fisher S, et al. Biological aspects of axonal damage in glaucoma: a brief review. Exp Eye Res. 2017;157:5–12.
CAS PubMed PubMed Central Article Google Scholar
Tezel G. Immune regulation toward immunomodulation for neuroprotection in glaucoma. Curr Opin Pharmacol. 2013;13(1):23–31.
CAS PubMed Article Google Scholar
Nickells RW, Howell GR, Soto I, John SW. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu Rev Neurosci. 2012;35:153–79.
CAS PubMed Article Google Scholar
Howell GR, Soto I, Zhu X, Ryan M, Macalinao DG, Sousa GL, et al. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J Clin Invest. 2012;122(4):1246–61.
CAS PubMed PubMed Central Article Google Scholar
Distante P, Lombardo S, Verticchio Vercellin AC, Raimondi M, Rolando M, Tinelli C, et al. Structure/function relationship and retinal ganglion cells counts to discriminate glaucomatous damages. BMC Ophthalmol. 2015;15:185.
PubMed PubMed Central Article Google Scholar
Vidal-Sanz M, Salinas-Navarro M, Nadal-Nicolás FM, Alarcón-Martínez L, Valiente-Soriano FJ, de Imperial JM, et al. Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas. Prog Retin Eye Res. 2012;31(1):1–27.
Soto I, Howell GR. The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect Med. 2014;4(8):a017269.
PubMed PubMed Central Article CAS Google Scholar
Qu J, Wang D, Grosskreutz CL. Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res. 2010;91(1):48–53.
CAS PubMed PubMed Central Article Google Scholar
Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020;12(11): e11686.
PubMed PubMed Central Google Scholar
Bengtsson B, Heijl A. Lack of visual field improvement after initiation of intraocular pressure reducing treatment in the Early Manifest Glaucoma Trial. Invest Opthalmol Vis Sci. 2016;57(13):5611–5.
Ahmed AYA, Althomali IHM, Althobaiti OMA, Assery MSF, Alsini AAN. Risk factors associated with glaucoma disease progression. Egypt J Hosp Med. 2018;73(3):6331–6.
Zhang N, Wang J, Chen B, Li Y, Jiang B. Prevalence of primary angle closure glaucoma in the last 20 years: a meta-analysis and systematic review. Front Med (Lausanne). 2021;7:624179.
Park HYL, Shin DY, Jeon SJ, Kim YC, Jung Y, Kim EK, et al. Predicting the development of normal tension glaucoma and related risk factors in normal tension glaucoma suspects. Sci Rep. 2021;11(1):16697.
CAS PubMed PubMed Central Article Google Scholar
McMonnies CW. Glaucoma history and risk factors. J Optom. 2017;10(2):71–8.
Dikopf MS, Vajaranant TS, Edward DP. Topical treatment of glaucoma: established and emerging pharmacology. Expert Opin Pharmacother. 2017;18(9):885–98.
CAS PubMed PubMed Central Article Google Scholar
Barar J, Javadzadeh AR, Omidi Y. Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin Drug Deliv. 2008;5(5):567–81.
CAS PubMed Article Google Scholar
Gaudana R, Jwala J, Boddu SH, Mitra AK. Recent perspectives in ocular drug delivery. Pharm Res. 2009;26(5):1197–216.
CAS PubMed Article Google Scholar
Hennessy AL, Katz J, Covert D, Protzko C, Robin AL. Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss. Ophthalmology. 2010;117(12):2345–52.
Thygesen J, Burk R, Carassa R, Crichton A, Goñi FJ, Menage M, et al. Criteria for choosing clinically effective glaucoma treatment: a discussion panel consensus. Curr Ther Res Clin Exp. 2007;68(3):127–36.
PubMed PubMed Central Article Google Scholar
Kwon S, Kim SH, Khang D, Lee JY. Potential therapeutic usage of nanomedicine for glaucoma treatment. Int J Nanomed. 2020;15:5745–65.
Duarte JN. Neuroinflammatory mechanisms of mitochondrial dysfunction and neurodegeneration in glaucoma. J Ophthalmol. 2021;2021:4581909.
PubMed PubMed Central Google Scholar
Patabendige A, Singh A, Jenkins S, Sen J, Chen R. Astrocyte activation in neurovascular damage and repair following ischaemic stroke. Int J Mol Sci. 2021;22(8):4280.
CAS PubMed PubMed Central Article Google Scholar
Thurgur H, Pinteaux E. Microglia in the neurovascular unit: blood-brain barrier-microglia interactions after central nervous system disorders. Neuroscience. 2019;405:55–67.
CAS PubMed Article Google Scholar
Ghosh AK, Rao VR, Wisniewski VJ, Zigrossi AD, Floss J, Koulen P, et al. Differential activation of glioprotective intracellular signaling pathways in primary optic nerve head astrocytes after treatment with different classes of antioxidants. Antioxidants (Basel). 2020;9(4):324.
CAS PubMed Central Article Google Scholar
Liu Y, Wu J, Yan LJ, Clark AF. High glucose impairs optic nerve head astrocyte phagocytosis prior to retinal ganglion cell degeneration. Invest Opthalmol Vis Sci. 2018;59(9):3549.
Nguyen JV, Soto I, Kim KY, Bushong EA, Oglesby E, Valiente-Soriano FJ, et al. Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. Proc Natl Acad Sci. 2011;108(3):1176–81.
CAS PubMed PubMed Central Article Google Scholar
Reichenbach A, Bringmann A. Glia of the human retina. Glia. 2020;68(4):768–96.
Vecino E, Rodriguez FD, Ruzafa N, Pereiro X, Sharma SC. Glia–neuron interactions in the mammalian retina. Prog Retin Eye Res. 2016;51:1–40.
CAS PubMed Article Google Scholar
Chong RS, Martin KR. Glial cell interactions and glaucoma. Curr Opin Ophthalmol. 2015;26(2):73–7.
PubMed PubMed Central Article Google Scholar
Ebneter A, Casson RJ, Wood JP, Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Opthalmol Vis Sci. 2010;51(12):6448–60.
Ginhoux F, Prinz M. Origin of microglia: current concepts and past controversies. Cold Spring Harb Perspect Biol. 2015;7(8):a020537.
PubMed PubMed Central Article Google Scholar
Chen M, Luo C, Zhao J, Devarajan G, Xu H. Immune regulation in the aging retina. Prog Retin Eye Res. 2019;69:159–72.
CAS PubMed Article Google Scholar
Silverman SM, Wong WT. Microglia in the retina: roles in development, maturity, and disease. Annu Rev Vis Sci. 2018;4:45–77.
Rathnasamy G, Foulds WS, Ling EA, Kaur C. Retinal microglia—a key player in healthy and diseased retina. Prog Neurobiol. 2019;173:18–40.
Abcouwer SF, Lin CM, Shanmugam S, Muthusamy A, Barber AJ, Antonetti DA. Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury. J Neuroinflamm. 2013;10:149.
留言 (0)